Tenaya Therapeutics Book Value Per Share Growth & History (TNYA)
Tenaya Therapeutics's book value per share was $0.57 for fiscal 2025.
View full Tenaya Therapeutics company overviewTenaya Therapeutics annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0.57 | -$0.50 | −47.00% |
| 2024 | 2024-12-31 | $1.07 | -$0.97 | −47.42% |
| 2023 | 2023-12-31 | $2.04 | -$1.60 | −43.95% |
| 2022 | 2022-12-31 | $3.64 | -$3.11 | −46.03% |
| 2021 | 2021-12-31 | $6.75 | $73.93 | — |
| 2020 | 2020-12-31 | -$67.19 | — | — |
Tenaya Therapeutics quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0.31 | -$0.30 | −49.46% |
| Q1 2026 | 2026-03-31 | $0.49 | -$0.24 | −33.33% |
| Q4 2025 | 2025-12-31 | $0.57 | -$0.50 | −47.00% |
| Q3 2025 | 2025-09-30 | $0.50 | -$0.92 | −64.99% |
| Q2 2025 | 2025-06-30 | $0.61 | -$1.09 | −63.94% |
| Q1 2025 | 2025-03-31 | $0.73 | -$1.28 | −63.57% |
| Q4 2024 | 2024-12-31 | $1.07 | -$0.97 | −47.42% |
| Q3 2024 | 2024-09-30 | $1.42 | -$1.00 | −41.29% |
| Q2 2024 | 2024-06-30 | $1.70 | -$1.10 | −39.31% |
| Q1 2024 | 2024-03-31 | $2.01 | -$1.21 | −37.46% |
| Q4 2023 | 2023-12-31 | $2.04 | -$1.60 | −43.95% |
| Q3 2023 | 2023-09-30 | $2.42 | -$2.32 | −48.98% |
| Q2 2023 | 2023-06-30 | $2.80 | -$2.61 | −48.29% |
| Q1 2023 | 2023-03-31 | $3.22 | -$2.81 | −46.58% |
| Q4 2022 | 2022-12-31 | $3.64 | -$3.11 | −46.03% |
| Q3 2022 | 2022-09-30 | $4.75 | -$2.61 | −35.50% |
| Q2 2022 | 2022-06-30 | $5.41 | $8.04 | — |
| Q1 2022 | 2022-03-31 | $6.03 | — | — |
| Q4 2021 | 2021-12-31 | $6.75 | $73.93 | — |
| Q3 2021 | 2021-09-30 | $7.36 | — | — |
| Q2 2021 | 2021-06-30 | -$2.63 | — | — |
| Q4 2020 | 2020-12-31 | -$67.19 | — | — |
Tenaya Therapeutics book value per share trends
Over the last five fiscal years, Tenaya Therapeutics's book value per share increased from -$67.19 to $0.57, a change of $67.75. The latest reported quarter, Q2 2026, shows $0.31.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tenaya Therapeutics source filings ↗